Understanding the Complexity of Non-Hodgkin Lymphoma

Acute Myeloid Leukemia Breast Cancer CLL Kidney Cancer Liver Cancer Lung Cancer Lymphoma Mantle Cell Lymphoma MPN Myeloma Ovarian Cancer Publications Skin Cancer

Cancer Type

View More Bladder Brain Breast Gastrointestinal Gynecologic Head & Neck Lung Lymphoma Myeloma Sarcoma Skin

Bladder Brain Breast Gastrointestinal Gynecologic Head & Neck Lung Lymphoma Myeloma Sarcoma Skin

About CURE

Press Releases Share Your Story Write for CURE

All News Blogs Caregiving Diet and Exercise Financial Psychosocial Recipes Sexual Health Side Effect Sponsored Survivorship

Videos

All Videos

CURE Connections

CURE Expert Connections

CURE Speaking Out

CURE TV

On Demand: Award Programs

On Demand: Patient Summits

On Demand: Webinars

All Videos CURE Connections CURE Expert Connections CURE Speaking Out CURE TV On Demand: Award Programs On Demand: Patient Summits On Demand: Webinars

Conferences

Conference Coverage

Conference Listing

Conference Coverage Conference Listing

Events

Award Programs

Educated Patient Summits

Educated Patient Webinars

Award Programs Educated Patient Summits Educated Patient Webinars

Advocacy Groups Art Gallery Journey Podcasts Publications Share Your Story

eNewsletter

CURE Magazine

HEAL Magazine

eNewsletter CURE Magazine HEAL Magazine

About
Advertise
Contact
TargetedOnc.com
OncLive.com
CancerNetwork.com
Terms & Conditions
Privacy
Do Not Sell My Information

Spotlight

Acute Myeloid Leukemia
Breast Cancer
CLL
Kidney Cancer
Liver Cancer
Lung Cancer
Lymphoma
Mantle Cell Lymphoma
MPN
Myeloma
Ovarian Cancer
Publications
Skin Cancer

Cancer TypeSee All >

Bladder
Brain
Breast
Gastrointestinal
Gynecologic
Head & Neck
Lung
Lymphoma
Myeloma
Sarcoma
Skin

About CURE

Press Releases
Share Your Story
Write for CURE

About
Advertise
Contact
TargetedOnc.com
OncLive.com
CancerNetwork.com
Terms & Conditions
Privacy
Do Not Sell My Information

October 29, 2018

$FDA Approves Xalkori for Children, Young Adults With Relapsed or Refractory Anaplastic Large Cell Lymphoma$

FDA Approves Xalkori for Children, Young Adults With Relapsed or Refractory Anaplastic Large Cell Lymphoma

$CAR-T Cell Therapy Product for Relapsed/Refractory Large B-Cell Lymphoma Still Under FDA Review$

CAR-T Cell Therapy Product for Relapsed/Refractory Large B-Cell Lymphoma Still Under FDA Review

Friday Frontline: Black Patients with Cancer at Higher Risk for COVID-19 Infections, Colts Punter Looks to Play Again After Successful Cancer Surgery and More

Latest News

Almost 5% of Patients Undergo Unnecessary Procedure to Remove Kidney and Nearby Tissue for Upper Tract Urothelial Carcinoma

FDA Grants Accelerated Approval to Trodelvy for Advanced Bladder Cancer

Webinar Recap: Know Your Lung Cancer: Accelerating Education and Access for Biomarker Testing

How a Young Patient With Cancer Made Me a Better Nurse

View More Latest News